Stay updated on HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.

Latest updates to the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check16 days agoChange DetectedA site-wide NIH notice announces updates and explains that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference0.3%

- Check23 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies its software revision as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check29 days agoChange DetectedThe site footer’s revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check50 days agoChange DetectedA new revision v3.7.0 was added to the study record history and v3.6.6 was removed, reflecting an update to the record's revision history.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6 in the history, indicating a small update to the page or its metadata.SummaryDifference0.0%

Stay in the know with updates to HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.